These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35774402)

  • 1. Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2.
    Zheng J; Miao J; Guo R; Guo J; Fan Z; Kong X; Gao R; Yang L
    Front Cell Infect Microbiol; 2022; 12():931061. PubMed ID: 35774402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could SARS-CoV-2-induced lung injury be attenuated by vitamin D?
    Xiao D; Li X; Su X; Mu D; Qu Y
    Int J Infect Dis; 2021 Jan; 102():196-202. PubMed ID: 33129966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
    Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
    Seif F; Aazami H; Khoshmirsafa M; Kamali M; Mohsenzadegan M; Pornour M; Mansouri D
    Int Arch Allergy Immunol; 2020; 181(6):467-475. PubMed ID: 32392562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential involvement of JAK-STAT signaling pathway in the COVID-19 infection assisted by ACE2.
    Luo J; Lu S; Yu M; Zhu L; Zhu C; Li C; Fang J; Zhu X; Wang X
    Gene; 2021 Feb; 768():145325. PubMed ID: 33253796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19.
    Sahebnasagh A; Mojtahedzadeh M; Najmeddin F; Najafi A; Safdari M; Rezai Ghaleno H; Habtemariam S; Berindan-Neagoe I; Nabavi SM
    Arch Med Res; 2020 Oct; 51(7):631-635. PubMed ID: 32863034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Many Faces of JAKs and STATs Within the COVID-19 Storm.
    Grant AH; Estrada A; Ayala-Marin YM; Alvidrez-Camacho AY; Rodriguez G; Robles-Escajeda E; Cadena-Medina DA; Rodriguez AC; Kirken RA
    Front Immunol; 2021; 12():690477. PubMed ID: 34326843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.
    Hariharan A; Hakeem AR; Radhakrishnan S; Reddy MS; Rela M
    Inflammopharmacology; 2021 Feb; 29(1):91-100. PubMed ID: 33159646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS).
    Neubauer A; Johow J; Mack E; Burchert A; Meyn D; Kadlubiec A; Torje I; Wulf H; Vogelmeier CF; Hoyer J; Skevaki C; Muellenbach RM; Keller C; Schade-Brittinger C; Rolfes C; Wiesmann T
    Leukemia; 2021 Oct; 35(10):2917-2923. PubMed ID: 34385593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications.
    Ting CT; Chen BS
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target.
    Xia B; Shen X; He Y; Pan X; Liu FL; Wang Y; Yang F; Fang S; Wu Y; Duan Z; Zuo X; Xie Z; Jiang X; Xu L; Chi H; Li S; Meng Q; Zhou H; Zhou Y; Cheng X; Xin X; Jin L; Zhang HL; Yu DD; Li MH; Feng XL; Chen J; Jiang H; Xiao G; Zheng YT; Zhang LK; Shen J; Li J; Gao Z
    Cell Res; 2021 Aug; 31(8):847-860. PubMed ID: 34112954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay.
    Galassi G; Marchioni A
    Acta Neurol Belg; 2021 Jun; 121(3):633-642. PubMed ID: 33811309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the pathophysiology of typical acute respiratory distress syndrome and severe COVID-19.
    Ball L; Silva PL; Giacobbe DR; Bassetti M; Zubieta-Calleja GR; Rocco PRM; Pelosi P
    Expert Rev Respir Med; 2022 Apr; 16(4):437-446. PubMed ID: 35341424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Could This Happen? : Narrowing Down the Contagion of COVID-19 and Preventing Acute Respiratory Distress Syndrome (ARDS).
    Allaerts W
    Acta Biotheor; 2020 Dec; 68(4):441-452. PubMed ID: 32335749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide induces acute lung injury and alveolar haemorrhage in association with the cytokine storm, coagulopathy and AT1R/JAK/STAT augmentation in a rat model that mimics moderate and severe Covid-19 pathology.
    Al-Ani B; ShamsEldeen AM; Kamar SS; Haidara MA; Al-Hashem F; Alshahrani MY; Al-Hakami AM; Kader DHA; Maarouf A
    Clin Exp Pharmacol Physiol; 2022 Apr; 49(4):483-491. PubMed ID: 35066912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory.
    Carcaterra M; Caruso C
    Med Hypotheses; 2021 Jan; 146():110412. PubMed ID: 33308936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
    Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
    J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).
    Speer G; Somogyi P
    Endocr J; 2021 Feb; 68(2):129-136. PubMed ID: 33473054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.